Compare ESCA & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESCA | CDXS |
|---|---|---|
| Founded | 1922 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.2M | 256.3M |
| IPO Year | 1995 | 2008 |
| Metric | ESCA | CDXS |
|---|---|---|
| Price | $18.63 | $2.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.1K | ★ 741.3K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.50% | N/A |
| EPS Growth | 6.45 | ★ 43.82 |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $180,541,000.00 | $138,590,000.00 |
| Revenue This Year | $4.15 | $7.73 |
| Revenue Next Year | N/A | $14.24 |
| P/E Ratio | $58.22 | ★ N/A |
| Revenue Growth | 2.71 | ★ 32.30 |
| 52 Week Low | $11.41 | $0.96 |
| 52 Week High | $21.32 | $3.87 |
| Indicator | ESCA | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 47.36 |
| Support Level | $17.33 | $2.41 |
| Resistance Level | $18.72 | $2.56 |
| Average True Range (ATR) | 0.57 | 0.15 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 43.19 | 25.22 |
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are the United States, Canada, Australia, and Other regions.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.